Concepts (218)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Atrial Appendage | 24 | 2024 | 76 | 5.930 |
Why?
|
| Atrial Fibrillation | 39 | 2026 | 737 | 5.190 |
Why?
|
| Catheter Ablation | 17 | 2026 | 321 | 2.250 |
Why?
|
| Stroke | 15 | 2023 | 1057 | 2.160 |
Why?
|
| Cardiac Surgical Procedures | 9 | 2023 | 1153 | 1.430 |
Why?
|
| Cardiac Catheterization | 6 | 2017 | 623 | 1.360 |
Why?
|
| Heart Conduction System | 10 | 2025 | 162 | 1.230 |
Why?
|
| Pulmonary Veins | 5 | 2024 | 166 | 0.900 |
Why?
|
| Septal Occluder Device | 4 | 2018 | 47 | 0.870 |
Why?
|
| Anticoagulants | 5 | 2021 | 601 | 0.810 |
Why?
|
| Thromboembolism | 3 | 2019 | 94 | 0.720 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 7 | 2026 | 73 | 0.620 |
Why?
|
| Heart Rate | 7 | 2020 | 573 | 0.570 |
Why?
|
| Tachycardia, Atrioventricular Nodal Reentry | 4 | 2026 | 32 | 0.530 |
Why?
|
| Treatment Outcome | 27 | 2026 | 12834 | 0.480 |
Why?
|
| Pericardium | 4 | 2020 | 103 | 0.470 |
Why?
|
| Cardiac Resynchronization Therapy Devices | 2 | 2014 | 17 | 0.460 |
Why?
|
| Tachycardia, Ventricular | 5 | 2024 | 257 | 0.390 |
Why?
|
| Suture Techniques | 4 | 2016 | 175 | 0.380 |
Why?
|
| Ligation | 9 | 2019 | 132 | 0.370 |
Why?
|
| Action Potentials | 5 | 2020 | 472 | 0.360 |
Why?
|
| Vena Cava, Superior | 1 | 2012 | 58 | 0.340 |
Why?
|
| Bundle-Branch Block | 1 | 2012 | 41 | 0.340 |
Why?
|
| Cardiac Resynchronization Therapy | 1 | 2012 | 48 | 0.340 |
Why?
|
| Cardiac Pacing, Artificial | 6 | 2011 | 132 | 0.330 |
Why?
|
| Vascular Malformations | 1 | 2012 | 103 | 0.320 |
Why?
|
| Preventive Health Services | 1 | 2011 | 58 | 0.320 |
Why?
|
| Equipment Design | 6 | 2020 | 535 | 0.310 |
Why?
|
| Defibrillators, Implantable | 4 | 2017 | 214 | 0.310 |
Why?
|
| Atrial Function, Left | 2 | 2020 | 35 | 0.300 |
Why?
|
| Punctures | 3 | 2020 | 51 | 0.300 |
Why?
|
| Humans | 60 | 2026 | 130436 | 0.300 |
Why?
|
| Aged | 32 | 2026 | 20888 | 0.290 |
Why?
|
| Cardiac Catheters | 3 | 2020 | 10 | 0.290 |
Why?
|
| Heart Injuries | 2 | 2020 | 49 | 0.270 |
Why?
|
| Arterio-Arterial Fistula | 1 | 2007 | 10 | 0.250 |
Why?
|
| Pacemaker, Artificial | 5 | 2010 | 192 | 0.250 |
Why?
|
| Body Surface Potential Mapping | 1 | 2026 | 18 | 0.240 |
Why?
|
| Atrioventricular Node | 1 | 2026 | 18 | 0.240 |
Why?
|
| Pericarditis | 2 | 2016 | 43 | 0.230 |
Why?
|
| Middle Aged | 29 | 2026 | 28395 | 0.230 |
Why?
|
| Electrocardiography | 6 | 2025 | 975 | 0.230 |
Why?
|
| Male | 40 | 2026 | 64471 | 0.220 |
Why?
|
| Organothiophosphorus Compounds | 1 | 2024 | 2 | 0.210 |
Why?
|
| Risk Assessment | 7 | 2025 | 3675 | 0.210 |
Why?
|
| Epicardial Mapping | 3 | 2019 | 9 | 0.200 |
Why?
|
| Electric Impedance | 3 | 2020 | 71 | 0.200 |
Why?
|
| Risk Factors | 10 | 2025 | 10948 | 0.200 |
Why?
|
| Pulmonary Artery | 1 | 2007 | 436 | 0.190 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2007 | 473 | 0.190 |
Why?
|
| Tachycardia, Supraventricular | 2 | 2017 | 106 | 0.190 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2007 | 284 | 0.190 |
Why?
|
| Postoperative Complications | 5 | 2023 | 3113 | 0.180 |
Why?
|
| Stents | 1 | 2007 | 781 | 0.170 |
Why?
|
| Echocardiography, Transesophageal | 2 | 2013 | 245 | 0.170 |
Why?
|
| Female | 36 | 2026 | 70351 | 0.160 |
Why?
|
| Cardiomyopathies | 3 | 2010 | 518 | 0.160 |
Why?
|
| Needles | 2 | 2020 | 49 | 0.150 |
Why?
|
| Heart Failure | 4 | 2023 | 2323 | 0.150 |
Why?
|
| Administration, Oral | 1 | 2021 | 708 | 0.150 |
Why?
|
| Recurrence | 2 | 2020 | 1472 | 0.150 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2007 | 747 | 0.140 |
Why?
|
| Cryosurgery | 2 | 2014 | 51 | 0.140 |
Why?
|
| Atrial Remodeling | 1 | 2017 | 16 | 0.130 |
Why?
|
| Mediastinum | 1 | 2017 | 44 | 0.130 |
Why?
|
| Incidence | 6 | 2025 | 3313 | 0.130 |
Why?
|
| Prospective Studies | 7 | 2025 | 6424 | 0.130 |
Why?
|
| Equipment Failure | 3 | 2017 | 124 | 0.120 |
Why?
|
| Echocardiography, Doppler, Color | 2 | 2016 | 110 | 0.120 |
Why?
|
| Registries | 3 | 2019 | 1607 | 0.120 |
Why?
|
| Long Term Adverse Effects | 1 | 2016 | 13 | 0.120 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2016 | 119 | 0.120 |
Why?
|
| Colchicine | 1 | 2015 | 39 | 0.120 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2016 | 42 | 0.120 |
Why?
|
| Cardiac Electrophysiology | 1 | 2015 | 15 | 0.110 |
Why?
|
| Heart-Assist Devices | 1 | 2024 | 1014 | 0.110 |
Why?
|
| Therapeutic Occlusion | 1 | 2015 | 3 | 0.110 |
Why?
|
| Prosthesis Fitting | 1 | 2015 | 10 | 0.110 |
Why?
|
| Catheterization | 2 | 2024 | 225 | 0.110 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2017 | 369 | 0.110 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2017 | 271 | 0.110 |
Why?
|
| Compassionate Use Trials | 1 | 2015 | 17 | 0.110 |
Why?
|
| Pericardial Effusion | 1 | 2015 | 72 | 0.110 |
Why?
|
| Intraoperative Complications | 1 | 2016 | 153 | 0.110 |
Why?
|
| Anesthesia | 1 | 2017 | 209 | 0.110 |
Why?
|
| Prosthesis Failure | 1 | 2015 | 158 | 0.100 |
Why?
|
| Aged, 80 and over | 7 | 2016 | 6788 | 0.100 |
Why?
|
| Retrospective Studies | 11 | 2024 | 17510 | 0.100 |
Why?
|
| Prosthesis Design | 1 | 2016 | 621 | 0.100 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2015 | 298 | 0.100 |
Why?
|
| Time Factors | 7 | 2026 | 6200 | 0.100 |
Why?
|
| Contraindications | 1 | 2013 | 75 | 0.100 |
Why?
|
| United States | 8 | 2019 | 11874 | 0.090 |
Why?
|
| Phlebography | 1 | 2012 | 40 | 0.090 |
Why?
|
| Predictive Value of Tests | 6 | 2020 | 2289 | 0.090 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2012 | 62 | 0.090 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 1270 | 0.080 |
Why?
|
| beta-Alanine | 1 | 2011 | 7 | 0.080 |
Why?
|
| Dabigatran | 1 | 2011 | 26 | 0.080 |
Why?
|
| Heart Neoplasms | 1 | 2012 | 108 | 0.080 |
Why?
|
| Ventricular Fibrillation | 1 | 2011 | 53 | 0.080 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2017 | 485 | 0.080 |
Why?
|
| Thrombosis | 1 | 2015 | 499 | 0.080 |
Why?
|
| Ventricular Function, Left | 2 | 2011 | 544 | 0.080 |
Why?
|
| Vagus Nerve Stimulation | 1 | 2011 | 67 | 0.080 |
Why?
|
| Ultrasonography, Interventional | 1 | 2012 | 205 | 0.080 |
Why?
|
| Hypertension | 1 | 2018 | 1348 | 0.080 |
Why?
|
| Benzimidazoles | 1 | 2011 | 155 | 0.080 |
Why?
|
| Electrodes, Implanted | 2 | 2017 | 176 | 0.080 |
Why?
|
| Warfarin | 1 | 2011 | 123 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2017 | 2060 | 0.080 |
Why?
|
| Myocarditis | 1 | 2010 | 132 | 0.070 |
Why?
|
| Marketing | 1 | 2009 | 8 | 0.070 |
Why?
|
| Sarcoma | 1 | 2012 | 218 | 0.070 |
Why?
|
| Anti-Obesity Agents | 1 | 2009 | 47 | 0.070 |
Why?
|
| Coronary Angiography | 2 | 2012 | 453 | 0.070 |
Why?
|
| Sheep | 2 | 2020 | 219 | 0.070 |
Why?
|
| Prosthesis-Related Infections | 1 | 2010 | 185 | 0.070 |
Why?
|
| Heart Atria | 3 | 2017 | 335 | 0.070 |
Why?
|
| Biopsy | 1 | 2012 | 1244 | 0.070 |
Why?
|
| Tachycardia, Ectopic Atrial | 1 | 2007 | 7 | 0.070 |
Why?
|
| Comorbidity | 1 | 2013 | 1583 | 0.070 |
Why?
|
| Autonomic Denervation | 1 | 2006 | 2 | 0.060 |
Why?
|
| Cicatrix | 1 | 2008 | 125 | 0.060 |
Why?
|
| Patient Selection | 1 | 2011 | 722 | 0.060 |
Why?
|
| Vagus Nerve | 1 | 2006 | 50 | 0.060 |
Why?
|
| Follow-Up Studies | 3 | 2025 | 5153 | 0.060 |
Why?
|
| Coronary Circulation | 1 | 2007 | 189 | 0.060 |
Why?
|
| Internet | 1 | 2009 | 422 | 0.060 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2008 | 363 | 0.060 |
Why?
|
| Dietary Supplements | 1 | 2009 | 449 | 0.060 |
Why?
|
| Equipment Failure Analysis | 2 | 2015 | 79 | 0.050 |
Why?
|
| Chest Pain | 1 | 2005 | 123 | 0.050 |
Why?
|
| Heart Ventricles | 3 | 2017 | 757 | 0.050 |
Why?
|
| Diaphragm | 1 | 2005 | 100 | 0.050 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2023 | 62 | 0.050 |
Why?
|
| Sick Sinus Syndrome | 1 | 2003 | 16 | 0.050 |
Why?
|
| Heart Block | 1 | 2003 | 37 | 0.050 |
Why?
|
| Coronary Vessels | 1 | 2006 | 524 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2024 | 307 | 0.050 |
Why?
|
| Adult | 9 | 2017 | 31120 | 0.050 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2002 | 54 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2024 | 1071 | 0.040 |
Why?
|
| Tetrazoles | 1 | 2002 | 71 | 0.040 |
Why?
|
| Device Removal | 1 | 2003 | 222 | 0.040 |
Why?
|
| Hospitals | 1 | 2023 | 437 | 0.040 |
Why?
|
| Steam | 1 | 2020 | 6 | 0.040 |
Why?
|
| Vasodilator Agents | 1 | 2002 | 198 | 0.040 |
Why?
|
| Therapeutic Irrigation | 1 | 2020 | 44 | 0.040 |
Why?
|
| Coronary Artery Bypass | 1 | 2004 | 515 | 0.040 |
Why?
|
| Poland | 1 | 2019 | 56 | 0.040 |
Why?
|
| Atrial Flutter | 1 | 2000 | 45 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2016 | 2896 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2010 | 2569 | 0.040 |
Why?
|
| Systole | 1 | 2018 | 195 | 0.030 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2000 | 231 | 0.030 |
Why?
|
| Magnesium | 1 | 2018 | 114 | 0.030 |
Why?
|
| Fibrinolytic Agents | 1 | 2019 | 189 | 0.030 |
Why?
|
| Potassium | 1 | 2018 | 266 | 0.030 |
Why?
|
| Sulfonamides | 1 | 2000 | 296 | 0.030 |
Why?
|
| Sodium | 1 | 2018 | 278 | 0.030 |
Why?
|
| Obesity | 1 | 2009 | 2383 | 0.030 |
Why?
|
| Reoperation | 1 | 2020 | 809 | 0.030 |
Why?
|
| Creatinine | 1 | 2018 | 396 | 0.030 |
Why?
|
| Swine | 1 | 2020 | 1184 | 0.030 |
Why?
|
| Animals | 4 | 2020 | 33857 | 0.030 |
Why?
|
| Hemorrhage | 1 | 2019 | 488 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2020 | 4667 | 0.030 |
Why?
|
| Surgical Wound Infection | 1 | 2017 | 263 | 0.030 |
Why?
|
| Iran | 1 | 2015 | 97 | 0.030 |
Why?
|
| Equipment Safety | 1 | 2015 | 34 | 0.030 |
Why?
|
| Patient Safety | 1 | 2019 | 445 | 0.030 |
Why?
|
| Sutures | 1 | 2014 | 62 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2015 | 258 | 0.030 |
Why?
|
| Retreatment | 1 | 2013 | 85 | 0.030 |
Why?
|
| History, 20th Century | 1 | 2015 | 363 | 0.030 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2015 | 192 | 0.020 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2015 | 276 | 0.020 |
Why?
|
| Syndrome | 2 | 2008 | 1158 | 0.020 |
Why?
|
| Fourier Analysis | 1 | 2011 | 54 | 0.020 |
Why?
|
| Drug Implants | 1 | 2010 | 43 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2017 | 3355 | 0.020 |
Why?
|
| Global Health | 1 | 2015 | 627 | 0.020 |
Why?
|
| Dogs | 1 | 2011 | 617 | 0.020 |
Why?
|
| Algorithms | 1 | 2016 | 1663 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2014 | 1342 | 0.020 |
Why?
|
| Temperature | 1 | 2009 | 289 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2010 | 444 | 0.020 |
Why?
|
| Infant | 1 | 2023 | 13228 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2010 | 534 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2023 | 14943 | 0.020 |
Why?
|
| Information Dissemination | 1 | 2009 | 194 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2009 | 461 | 0.010 |
Why?
|
| Prosthesis Implantation | 1 | 2007 | 151 | 0.010 |
Why?
|
| Weight Loss | 1 | 2009 | 533 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2015 | 4035 | 0.010 |
Why?
|
| Foreign-Body Migration | 1 | 2005 | 64 | 0.010 |
Why?
|
| Cardiac Care Facilities | 1 | 2004 | 11 | 0.010 |
Why?
|
| Databases as Topic | 1 | 2004 | 73 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2008 | 1239 | 0.010 |
Why?
|
| Prevalence | 1 | 2010 | 2683 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2008 | 1875 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2007 | 948 | 0.010 |
Why?
|
| Intermittent Claudication | 1 | 2002 | 48 | 0.010 |
Why?
|
| Prognosis | 1 | 2010 | 4861 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2004 | 1483 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2004 | 1388 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 3749 | 0.010 |
Why?
|
| Hospital Mortality | 1 | 2004 | 1059 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2000 | 564 | 0.010 |
Why?
|
| Length of Stay | 1 | 2004 | 1400 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 2004 | 998 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2000 | 1374 | 0.010 |
Why?
|
| Young Adult | 1 | 2009 | 9993 | 0.010 |
Why?
|
| Texas | 1 | 2004 | 3642 | 0.010 |
Why?
|
| Adolescent | 1 | 2013 | 20725 | 0.010 |
Why?
|
| Logistic Models | 1 | 2000 | 1793 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2004 | 5034 | 0.010 |
Why?
|